Board of Directors

Dr Edgar has extensive experience in financial services, including 25 years at ANZ Bank where he retired as Deputy Chief Executive Officer.
Special responsibilities: Board Chair

Professor Mitchell is Dean, Faculty of Medicine, Nursing and Health Sciences at Monash University, having trained as a physician scientist specialising in clinical haematology. She was the first woman to be appointed Dean of Medicine of a Go8 University in Australia. Her research group has focused on the molecular drivers of human cancer. Prof Mitchell is an inductee on the Victorian Honour Roll of Women and a recipient of the Lemberg Medal. She is an Order of Australia award recipient for distinguished service to medicine in the field of haematology, to medical education and research, and to academic leadership. Prof Mitchell is a Fellow of the Australian Academy of Health and Medical Sciences. She is Council Chair, Monash Partners Academic Health Sciences Centre and is a Director on the boards of Alfred Health and The Sylvia and Charles Viertel Charitable Foundation Medical Advisory Board.

Professor Anderson is an Emeritus Professor at Monash University, and Chair of Global Biodata Coalition. He was previously Secretary-General of the international organisation Human Frontier Science Program, as well as CEO of the NHMRC and a member of numerous national and international medical research bodies. He has held academic and research positions at Monash University, Baker Medical Research Institute, University of Sydney and Harvard Medical School.

Mr Leyden is Managing Director and CEO of Lazard Australia Pty Ltd, an independent corporate advisory firm. He has worked in the investment banking industry in Australia for over 30 years and has experience across a range of industries, including healthcare, energy, infrastructure, resources and financial services.
Special responsibilities: Investment Committee Chair

Mr Dodd is a Senior Partner at PwC and has over 30 years of accounting and finance experience. He provides services to clients in the ASX100 across mining, infrastructure, technology and many other industries. He spent two years working in the UK and shorter stints in Asia and Africa. He is also a Director on the boards of Peter MacCallum Cancer Foundation and Loreto Ministries.
Special responsibilities: Finance and Audit Committee Chair 

Mr Ou was appointed Executive Director of Financial Resources Management Division at Monash University in 2018 and leads a team responsible for developing and managing Monash’s budget and monitoring the university’s financial performance. He joined Monash University in 2001 and has held various middle and senior management roles within the Finance portfolio. He has extensive experience in financial management, is a certified practicing accountant with CPA Australia and holds an MBA from Monash University.
Special responsibilities: Finance and Audit Committee Member

Professor Hennessy is a Vice Chancellor’s Professorial Fellow at Monash University and sits on many private sector and for-purpose boards as a non-executive Director, Chair and Strategic Advisor. Before entering parliament Prof Hennessy practised as a private sector solicitor and was a senior political and legal advisor. She served as the Minister for Health, Minister for Ambulance Services and Minister for Workplace Service before becoming the Attorney-General. She holds a Bachelor of Laws and Bachelor of Arts from Monash University as well as a Master of Public and International Law from the University of Melbourne. Her current appointments include Chair of Western Heath, Chair of Gaiso Theranostics Pty Ltd, Chair of Monash Women’s Health Alliance, Non-Executive Director of Premit P/L, MTIC, Scope (Aust) and Incolink. She is a recipient of the Thornett Award for Promotion of Reason and an ambassador for The McKinnon Prize in Political Leadership.

Mr Merriel is a certified practicing accountant (CPA) with over 40 years of experience working in medical research (Hudson Institute of Medical Research and Baker Institute), large public healthcare services (Melbourne Health and Southern Health) and commercial organisations (Pacific Dunlop and Deloitte Consulting). He has been a Director of two Venture Capital Funds and a Director and Company Secretary of several biotechnology focused medical research institute spin off companies. He is currently the Company Secretary and a Director of both Exosome BioSciences Pty Ltd and Hudson Institute Investment Holdings Pty Ltd.
Special responsibilities: Finance and Audit Committee Secretary, Investment Committee Member, Intellectual Property and Commercialisation Committee Acting Chair and Secretary

Prior to moving to Melbourne in 2024 to lead Monash Health, Eugine was CEO at University Hospitals Bristol and Weston NHS Foundation Trust in England.  He has held senior roles across the English National Health System and has consistently been recognised for his leadership and passion for whole systems approach to health, health equity and outcomes.  He was appointed Visiting Professor for the College of Health, Science and Society at University of the West of England and was a board member of the NHS Race and Health Observatory. Eugine is also Adjunct Clinical Professor in the School of Clinical Sciences at Monash University.